-
Recursion Pharmaceuticals (NASDAQ:RXRX) Given New $6.00 Price Target at Leerink Partners
Source: Buzz FX / 28 Feb 2025 16:10:15 America/Chicago
Recursion Pharmaceuticals (NASDAQ:RXRX) Given New $6.00 Price Target at Leerink Partners Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Recursion Pharmaceuticals ( NASDAQ:RXRX - Get Free Report ) had its price objec
Read more...